SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.84+1.8%Dec 19 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Clive Roberts who wrote (1455)8/23/2000 10:18:07 AM
From: scaram(o)uche  Read Replies (1) of 52153
 
Clive:

Yeah, I sold some shares down there, too. Sold most at about $7, shortly after the institutional offering led by Van Kasper -- but then suffered, bitching for what seemed forever, under the guidance of Price.

So who do you think is available for a song.

Stuff that I consider to be unreasonably cheap, down in dead-money land..... MCDE (including chunk of Iconix), NBSC (including over 80% of DGI), and KDUS. MCDE has at least one seller, potential downside on "lack of cash" concern, and a history of poor performance, and the latter two are completely illiquid.... you can't sell if you buy. VPHM has now popped.... it was a no-brainer a couple of weeks ago, and it still looks cheap to me.

I also still like BTRN, NBIX and NRGN for relative valuations.

Mostly out-of or not-in favor stuff. Would not recommend moving on anything in the sector, at this time, without tons of homework. Lotsa downside potential for many or most issues.

Cheers! Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext